Welcome to PsychU!

A Patient & Caregiver’s Guide: Recognizing & Responding To Residual Symptoms Of Major Depressive Disorder (MDD)

While remission is the goal in treatment of patients with major depressive disorder (MDD), residual or lingering symptoms are common, even among remitters, and can negatively affect patient functioning and outcomes. This factsheet will review the prevalence of MDD, discuss the prevalence and impact of residual symptoms, and review strategies for addressing residual symptoms in patients with MDD.

If you or someone you know is in crisis, call the Suicide Prevention Hotline/Lifeline at 1-800-273-TALK (8255)
or text the Crisis Text line at 741-741

PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

US.CORP.X.21.00347 / US.CORP.X.21.00297